We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

25 hedge funds and large institutions have $1.71M invested in Allena Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

8% less capital invested

Capital invested by funds: $1.86M → $1.71M (-$156K)

11% less funds holding

Funds holding: 28 → 25 (-3)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
8
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$194K
2
TSS
Two Sigma Securities
New York
+$55.3K
3
Millennium Management
Millennium Management
New York
+$26.9K
4
Citigroup
Citigroup
New York
+$26.7K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$15.6K

Top Sellers

Rank Fund Capital Flow
1
FM
Frazier Management
Washington
-$236K
2
BCM
Bridgeway Capital Management
Texas
-$29K
3
VF
Virtu Financial
New York
-$10K
4
Citadel Advisors
Citadel Advisors
Florida
-$9K
5
BlackRock
BlackRock
New York
-$4.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP II
Massachusetts
$533K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$512K +$15.6K +100,952 +4%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$239K +$194K +1,250,988 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$73K +$7.87K +50,779 +15%
TSS
5
Two Sigma Securities
New York
$68K +$55.3K +357,044 New
BlackRock
6
BlackRock
New York
$44K -$4.76K -30,705 -12%
State Street
7
State Street
Massachusetts
$39K – – –
Citigroup
8
Citigroup
New York
$33K +$26.7K +172,388 +6,630%
Millennium Management
9
Millennium Management
New York
$33K +$26.9K +173,798 New
KAS
10
Kestra Advisory Services
Texas
$31K -$1.32K -8,500 -5%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$20K – – –
Northern Trust
12
Northern Trust
Illinois
$17K – – –
UBS Group
13
UBS Group
Switzerland
$16K +$10.8K +69,893 +502%
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$13K +$1.14K +7,388 +13%
LFAS
15
Level Four Advisory Services
Texas
$8K – – –
LPL Financial
16
LPL Financial
California
$6K – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$6K – – –
GG
18
Golden Green
South Carolina
$5K – – –
1IA
19
1620 Investment Advisors
Massachusetts
$3K +$2.32K +15,000 New
Renaissance Technologies
20
Renaissance Technologies
New York
$3K +$2.66K +17,200 New
SWM
21
Spire Wealth Management
Virginia
$2K +$8 +53 +0.5%
PFS
22
Prospera Financial Services
Texas
$2K +$813 +5,250 +95%
Bank of America
23
Bank of America
North Carolina
$1K – – –
FM
24
Frazier Management
Washington
– -$236K -1,019,288 Closed
BCM
25
Bridgeway Capital Management
Texas
– -$29K -124,200 Closed
1
2

ALNA Hedge Fund Activity: Q2 2022 in Review

25 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q2 2022, worth a combined $1.71M — down 8.4% from $1.86M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ALNA and 5 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 8 added.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $194K. The largest seller was Frazier Management, exiting entirely with an estimated $236K sold.

  • 25 institutional investors held Allena Pharmaceuticals (ALNA) as of Q2 2022, down from 28 in Q1 2022.
  • Funds reported $1.71M of Allena Pharmaceuticals stock for Q2 2022, down 8.4% quarter-over-quarter.
  • 5 funds opened new Allena Pharmaceuticals positions in Q2 2022 and 8 closed out, a net change of -3 holders.
  • The largest Allena Pharmaceuticals buyer in Q2 2022 was Acadian Asset Management, an estimated $194K added.
  • The largest Allena Pharmaceuticals seller in Q2 2022 was Frazier Management, an estimated $236K sold.

Based on aggregated 13F filings for Q2 2022.